# Biotech Growth Trust PLC (BIOG)

**Page:** https://fundology.uk/fund/biog · ISIN GB0000385517

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 13/11/2026, BIOG (Biotech Growth Trust PLC, ISIN GB0000385517) closed at £14.00 on the London Stock Exchange. Over the five years to 13/11/2026 its price changed by +15.3% (income paid out is not included), or −10.0% after UK CPIH inflation.

## Summary

Biotech Growth Trust PLC is an investment trust. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share.

Latest close: **£14.00** (13/11/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | BIOG |
| ISIN | GB0000385517 |
| Category | Investment trusts |
| Type | Investment trust |
| Domicile | United Kingdom |

## Past returns (periods to 13/11/2026)

After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation.

| Window | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 1 year | +31.46% | +26.80% | price only |
| 3 years | +91.52% | +73.03% | price only |
| 5 years | +15.32% | -9.99% | price only |

Returns: worked out from recorded daily closes. Inflation: UK CPIH, latest month published.

## Calendar-year returns

Calendar-year returns of Biotech Growth Trust PLC in pounds (price only, income paid out not included): 2022 −22.1%, 2023 −3.5%, 2024 −0.9%, 2025 +35.4%; 2026 to 13/11/2026 +16.7%. Returns of Biotech Growth Trust PLC in pounds (price only, income paid out not included) over the 12 months to 30/09/2026: +51.0%; to 30/09/2025: +0.1%; to 30/09/2024: +32.0%; to 30/09/2023: −21.9%; to 30/09/2022: −15.3%.

| Year | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 2022 | -22.1% | -28.6% | Price |
| 2023 | -3.5% | -7.3% | Price |
| 2024 | -0.9% | -4.3% | Price |
| 2025 | +35.4% | +30.8% | Price |
| 2026 to 13/11/2026 | +16.7% | +12.9% | Price |

## Risk metrics

| Window | Volatility | Max drawdown |
|---|---|---|
| 1 year | 26.86% | -23.82% |
| 3 years | 27.62% | -38.49% |
| 5 years | 26.68% | -46.29% |

## Largest fall

Volatility of Biotech Growth Trust PLC in pounds, annualised from weekly returns to 13/11/2026: 26.9% over 1 year, 27.6% over 3 years, 26.7% over 5 years. Largest fall in the price of Biotech Growth Trust PLC since November 2021, in pounds: −46.3% from 24/12/2021 to 11/04/2025. The lowest 12-month return of Biotech Growth Trust PLC in pounds (price only, income paid out not included) since January 2021 was −45.1% (12 months to 04/02/2022); the highest was +112.3% (12 months to 26/06/2026). On 13/11/2026 the price of Biotech Growth Trust PLC was 19.4% below its highest weekly close since November 2021 (28/08/2026), in pounds.

## Charges & eligibility

- Stocks and shares ISA eligible: usually (check with your platform)
- SIPP eligible: usually (check with your provider)
- ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify.

## Questions people ask

**What is the ISIN of BIOG?**

The ISIN of BIOG is GB0000385517. An ISIN identifies one exact share class of a fund; BIOG is its ticker on the London Stock Exchange.

**What were BIOG’s returns in each of the last five years?**

Calendar-year returns of BIOG in pounds (price only, income paid out not included): 2022 −22.1%, 2023 −3.5%, 2024 −0.9%, 2025 +35.4%; 2026 to 13/11/2026 +16.7%. Past performance is not a guide to future returns.

**How has BIOG done after inflation?**

Over the five years to 13/11/2026 BIOG’s price changed by +15.3% (income paid out is not included), or −10.0% after UK CPIH inflation. Past performance is not a guide to future returns.

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.